HIGH EXPRESSION OF DNMT3B NEGATIVELY IMPACTS ON CLINICAL OUTCOME OF OLDER PATIENTS (PTS) WITH PRIMARY CYTOGENETICALLY NORMAL (CN) ACUTE MYELOID LEUKEMIA (AML) [CALGB 20202 (ALLIANCE)]

被引：0
|
作者：
Niederwieser, C. [1 ]
Kohlschmidt, J. [1 ,2 ]
Maharry, K. [1 ,2 ]
Mrozek, K. [1 ]
Metzeler, K. [1 ]
Volinia, S. [1 ]
Yan, P. [1 ]
Frankhouser, D. [1 ]
Whitman, S. [1 ]
Becker, H. [1 ]
Eisfeld, A. [1 ]
Schwind, S. [1 ]
Curfman, J. [1 ]
Wu, Y. [1 ]
Baer, M. [3 ]
Powell, B. [4 ]
Kolitz, J. [5 ]
Moore, J. [6 ]
Carter, T. [7 ]
Marcucci, G. [1 ]
Bloomfield, C. [1 ]
机构：
[1] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH 43210 USA
[2] Mayo Clin, Alliance Clin Trials Oncol Stat & Data Ctr, Rochester, MN USA
[3] Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA
[4] Wake Forest Univ, Comprehens Canc Ctr, Winston Salem, NC 27109 USA
[5] Hofstra North Shore Long Isl Jewish Sch Med, Monter Canc Ctr, Lake Success, NY USA
[6] Duke Univ, Med Ctr, Durham, NC 27706 USA
[7] Univ Iowa, Iowa City, IA USA
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
S1168
引用
收藏
页码：484 / 484
页数：1
相关论文
共 50 条
  • [1] Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemia
    Niederwieser, C.
    Kohlschmidt, J.
    Volinia, S.
    Whitman, S. P.
    Metzeler, K. H.
    Eisfeld, A-K
    Maharry, K.
    Yan, P.
    Frankhouser, D.
    Becker, H.
    Schwind, S.
    Carroll, A. J.
    Nicolet, D.
    Mendler, J. h
    Curfman, J. P.
    Wu, Y-Z
    Baer, M. R.
    Powell, B. L.
    Kolitz, J. E.
    Moore, J. O.
    Carter, T. H.
    Bundschuh, R.
    Larson, R. A.
    Stone, R. M.
    Mrozek, K.
    Marcucci, G.
    Bloomfield, C. D.
    LEUKEMIA, 2015, 29 (03) : 567 - 575
  • [2] Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemia
    C Niederwieser
    J Kohlschmidt
    S Volinia
    S P Whitman
    K H Metzeler
    A-K Eisfeld
    K Maharry
    P Yan
    D Frankhouser
    H Becker
    S Schwind
    A J Carroll
    D Nicolet
    J H Mendler
    J P Curfman
    Y-Z Wu
    M R Baer
    B L Powell
    J E Kolitz
    J O Moore
    T H Carter
    R Bundschuh
    R A Larson
    R M Stone
    K Mrózek
    G Marcucci
    C D Bloomfield
    Leukemia, 2015, 29 : 567 - 575
  • [3] Higher MN1 expression is an unfavorable prognosticator in older patients (Pts) with cytogenetically normal acute myeloid leukemia (CN-AML): A CALGB study
    Schwind, Sebastian
    Marcucci, Guido
    Holland, Kelsi B.
    Mrozek, Krzysztof
    Michael, Radmacher D.
    Maharry, Kati
    Becker, Heiko
    Whitman, Susan P.
    Wu, Yue-Zhong
    Carter, Thomas H.
    Powell, Bayard L.
    Caligiuri, Michael A.
    Baer, Maria R.
    Larson, Richard A.
    Bloomfield, Clara D.
    CANCER RESEARCH, 2010, 70
  • [4] Adverse Prognostic Impact of GAS6 Expression in De Novo Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) (CALGB 8461, 9665, 20202; Alliance)
    Whitman, Susan
    Kohlschmidt, Jessica
    Maharry, Kati
    Nicolet, Deedra
    Schwind, Sebastian
    Becker, Heiko
    Metzeler, Klaus H.
    Mrozek, Krzysztof
    Mendler, Jason H.
    Eisfeld, Ann-Kathrin
    Volinia, Stefano
    Powell, Bayard L.
    Carter, Thomas H.
    Kolitz, Jonathan E.
    Stone, Richard M.
    Park, Il-Kyoo
    Caligiuri, Michael A.
    Marcucci, Guido
    Bloomfield, Clara D.
    BLOOD, 2012, 120 (21)
  • [5] Roles of DNMT3B and PARP1 Genes Expression in Cytogenetically Normal Acute Myeloid Leukemia
    Mahmoud, Hager A.
    Botros, Shahira K. A.
    Fouad, Abdelhamid Mohamed
    Kamel, Mahmoud M.
    Aziz, Rania S. Abdel
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2024, 18
  • [6] MicroRNA (miR) expression signatures in molecular subsets of cytogenetically normal (CN) acute myeloid leukemia (AML): A Cancer and Leukemia Group B (CALGB) study
    Radmacher, M. D.
    Marcucci, G.
    Paschka, P.
    Vukosavljevic, T.
    Whitman, S. P.
    Ruppert, A. S.
    Mrozek, K.
    Kolitz, J. E.
    Larson, R. A.
    Bloomfield, C. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [7] High BAALC expression associates with other molecular prognostic markers, poor outcome and a distinct gene expression signature in cytogenetically normal acute myeloid leukemia (CN AML): A Cancer and Leukemia Group B (CALGB) study
    Langer, C.
    Ruppert, A. S.
    Radmacher, M. D.
    Whitman, S. P.
    Paschka, P.
    Baldus, C. D.
    Mrozek, K.
    Kolitz, J. E.
    Marcucci, G.
    Bloomfield, C. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [8] Low Meningioma 1 (MN1) gene expression to predict outcome in cytogenetically normal acute myeloid leukemia (CN-AML): A Cancer and Leukemia Group B (CALGB) study
    Langer, C.
    Maharry, K.
    Mrozek, K.
    Paschka, P.
    Whitman, S. P.
    Kolitz, J. E.
    Larson, R. A.
    Marcucci, G.
    Bloomfield, C. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] Heritable polymorphism predisposes to high expression of BAALC in cytogenetically normal acute myeloid leukemia (CN-AML)
    Eisfeld, Ann-Kathrin
    Marcucci, Guido
    Liyanarachchi, Sandya
    Doehner, Konstanze
    Schwind, Sebastian
    Maharry, Kati
    Nicolet, Deedra
    Radmacher, Michael D.
    Doehner, Hartmut
    Tanner, Stephan M.
    Bloomfield, Clara D.
    de la Chapelle, Albert
    CANCER RESEARCH, 2012, 72
  • [10] DNA Methyltransferase 3B (DNMT3B) Protein Expression Predicts Survival in Patients with Acute Myeloid Leukemia (AML)
    Sauer, Tim
    Drusio, Christina
    Wisudanto, Irawan
    Friedel, Kim
    Tschanter, Petra
    Thoennissen, Nils H.
    Sauerland, Cristina
    Koehler, Gabriele
    Buechner, Thomas
    Berdel, Wolfgang E.
    Krug, Utz
    Mueller-Tidow, Carsten
    BLOOD, 2012, 120 (21)
12345